Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13776
Country/Region: Mozambique
Year: 2017
Main Partner: Center for Collaboration in Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $19,288,791 Additional Pipeline Funding: $2,400,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $2,212,552
Care: TB/HIV (HVTB) $780,194
Care: Pediatric Care and Support (PDCS) $362,658
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $29,117
Testing: HIV Testing and Counseling (HVCT) $371,628
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $2,057,629
Treatment: Adult Treatment (HTXS) $12,699,766
Treatment: Pediatric Treatment (PDTX) $775,247
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2018 45
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2018 76
GEND_GBV <10, Male, Physical and/or Emotional Violence 2018 950
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2018 12
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2018 144
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2018 297
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2018 1,111
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2018 45
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2018 144
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2018 393
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2018 1,253
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2018 45
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2018 12
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2018 438
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2018 1,157
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2018 45
GEND_GBV 25-49, Female, Physical and/or Emotional Violence 2018 45
GEND_GBV 25-49, Female, Sexual Violence (Post-Rape Care) 2018 406
GEND_GBV 25-49, Male, Physical and/or Emotional Violence 2018 95
GEND_GBV 25-49, Male, Sexual Violence (Post-Rape Care) 2018 12
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2018 438
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2018 30
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 1,359
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 5,437
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 1,839
GEND_GBV Number of people receiving post-GBV care 2018 7,198
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 18,360
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 674,426
HTS_TST Service Delivery Point Agg Age (Facility) ANC: <15, Negative 2018 112
HTS_TST Service Delivery Point Agg Age (Facility) ANC: 15+, Negative 2018 7,122
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 366
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 108
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 316
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 93
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 1,704
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 182
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 1,221
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 130
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Female, Negative 2018 19
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: <15, Male, Negative 2018 16
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 34
HTS_TST Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 8
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Negative 2018 529
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Negative 2018 474
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 4,891
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 1,239
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Female, Negative 2018 1
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Male, Negative 2018 2
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 43
HTS_TST Service Delivery Point Agg Age (Facility) VCT: <15, Female, Negative 2018 65
HTS_TST Service Delivery Point Agg Age (Facility) VCT: <15, Male, Negative 2018 55
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Negative 2018 1,131
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Negative 2018 753
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: <15, Negative 2018 1,144
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 70,893
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 875
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 766
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 2,534
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 699
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 22,676
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 20,546
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 320,570
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 81,072
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 131
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 148
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 1,275
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 1,745
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 1,153
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 953
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 56,105
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 37,476
HTS_TST Sum of Test Result disaggregates 2018 1,355
HTS_TST Sum of Test Result disaggregates 2018 50,060
HTS_TST_POS By Test Result: Positive 2018 1,355
HTS_TST_POS By Test Result: Positive 2018 50,060
HTS_TST_POS Service Delivery Point Agg Age (Facility) ANC: 15+, Positive 2018 300
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 303
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 33
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 212
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 22
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 11
HTS_TST_POS Service Delivery Point Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Positive 2018 15
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 269
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 83
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: <15, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Female, Positive 2018 9
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Male, Positive 2018 11
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: <15, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: <15, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Positive 2018 338
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Positive 2018 233
HTS_TST_POS Service Delivery Point by Agg Age (Community) VCT Mod: <15, Female, Positive 2018 108
HTS_TST_POS Service Delivery Point by Agg Age (Community) VCT Mod: <15, Male, Positive 2018 80
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: <15, Positive 2018 16
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 7,119
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 27
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 514
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 260
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 600
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 512
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 18,509
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 5,760
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 29
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive 2018 12
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 535
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 670
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 8,715
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 6,052
PMTCT_ART Already on ART at beginning of current pregnancy 2018 271
PMTCT_ART Already on ART at beginning of current pregnancy 2018 4,753
PMTCT_ART New on ART 2018 329
PMTCT_ART New on ART 2018 7,544
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 600
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 12,297
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 7,842
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 84,459
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 582
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 11,798
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 163
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 3,553
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 363
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 7,856
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 35
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 231
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 21
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 158
PMTCT_STAT By Age (Numerator): : 15-19 2018 1,626
PMTCT_STAT By Age (Numerator): 10-14 2018 36
PMTCT_STAT By Age (Numerator): 10-14 2018 416
PMTCT_STAT By Age (Numerator): 15-19 2018 17,510
PMTCT_STAT By Age (Numerator): 20-24 2018 2,647
PMTCT_STAT By Age (Numerator): 20-24 2018 28,536
PMTCT_STAT By Age (Numerator): 25-49 2018 3,527
PMTCT_STAT By Age (Numerator): 25-49 2018 37,999
PMTCT_STAT By known positives: 15-19 2018 26
PMTCT_STAT By known positives: 20-24 2018 90
PMTCT_STAT By known positives: 25-49 2018 197
PMTCT_STAT By new negatives: 10-14 2018 34
PMTCT_STAT By new negatives: 15-19 2018 1,533
PMTCT_STAT By new negatives: 20-24 2018 2,351
PMTCT_STAT By new negatives: 25-49 2018 2,881
PMTCT_STAT By new positives: 15-19 2018 69
PMTCT_STAT By new positives: 20-24 2018 106
PMTCT_STAT By new positives: 25-49 2018 129
PMTCT_STAT By Number of known positives: 15-19 2018 416
PMTCT_STAT By Number of known positives: 20-24 2018 1,524
PMTCT_STAT By Number of known positives: 25-49 2018 3,346
PMTCT_STAT By Number of new negative: 10-14 2018 387
PMTCT_STAT By Number of new negative: 15-19 2018 16,102
PMTCT_STAT By Number of new negative: 20-24 2018 24,705
PMTCT_STAT By Number of new negative: 25-49 2018 30,261
PMTCT_STAT By Number of new positives: 10-14 2018 61
PMTCT_STAT By Number of new positives: 15-19 2018 1,641
PMTCT_STAT By Number of new positives: 20-24 2018 2,494
PMTCT_STAT By Number of new positives: 25-49 2018 3,001
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 7,842
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 84,459
PMTCT_STAT_den By Age (Denominator): <15-19 2018 19,813
PMTCT_STAT_den By Age (Denominator): 10-14 2018 81
PMTCT_STAT_den By Age (Denominator): 10-14 2018 862
PMTCT_STAT_den By Age (Denominator): 15-19 2018 1,837
PMTCT_STAT_den By Age (Denominator): 20-24 2018 2,645
PMTCT_STAT_den By Age (Denominator): 20-24 2018 28,494
PMTCT_STAT_den By Age (Denominator): 25-49 2018 3,357
PMTCT_STAT_den By Age (Denominator): 25-49 2018 36,139
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 9
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 414
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 106
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 2,832
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 9
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 414
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 122
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 3,293
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 245
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 6,934
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 245
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 6,934
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 9
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 414
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 106
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 2,832
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 9
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 414
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 122
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 3,293
TB_PREV By Age/Sex (Numerator): <15, Female 2018 33
TB_PREV By Age/Sex (Numerator): <15, Female 2018 561
TB_PREV By Age/Sex (Numerator): <15, Male 2018 33
TB_PREV By Age/Sex (Numerator): <15, Male 2018 561
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 544
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 23,293
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 301
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 12,923
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 906
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 37,316
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 1,133
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 46,650
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 43
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 713
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 43
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 713
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 677
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 29,116
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 376
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 16,162
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 24
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 707
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 288
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 4,946
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 24
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 707
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 337
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 5,760
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 672
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 12,105
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 672
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 12,105
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 24
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 707
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 288
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 4,946
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 24
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 707
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 337
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 5,760
TX_CURR Aggregated Age/Sex: <15 Female 2018 371
TX_CURR Aggregated Age/Sex: <15 Female 2018 6,529
TX_CURR Aggregated Age/Sex: <15 Male 2018 371
TX_CURR Aggregated Age/Sex: <15 Male 2018 6,529
TX_CURR Aggregated Age/Sex: 15+ Female 2018 4,806
TX_CURR Aggregated Age/Sex: 15+ Female 2018 136,471
TX_CURR Aggregated Age/Sex: 15+ Male 2018 2,665
TX_CURR Aggregated Age/Sex: 15+ Male 2018 75,765
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 8,204
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 225,257
TX_CURR Sum of Aggregated Age/Sex <15 2018 742
TX_CURR Sum of Aggregated Age/Sex <15 2018 13,058
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 7,471
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 212,236
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 8,213
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 225,294
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 42
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 777
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 36
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 774
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 754
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 32,351
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 418
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 17,955
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 1,258
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 51,829
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 1,250
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 51,857
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 1,666
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 112,145
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 1,334
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 94,990
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 18
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 149
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 18
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 149
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 18
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 153
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 18
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 149
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 61
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 51,819
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 744
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 8,600
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 35
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 29,149
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 420
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 4,833
TX_PVLS Numerator: Indication: Routine 2018 133
TX_PVLS Numerator: Indication: Routine 2018 81,266
TX_PVLS Numerator: Indication: Targeted 2018 1,201
TX_PVLS Numerator: Indication: Targeted 2018 13,724
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 18
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 15,544
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 221
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 2,581
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 18
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 15,544
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 221
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 2,581
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 23
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 180
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 23
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 180
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 23
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 180
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 23
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 180
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 76
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 60,984
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 931
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 10,325
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 42
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 34,303
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 524
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 5,808
TX_PVLS_den Denominator: Indication: Routine 2018 165
TX_PVLS_den Denominator: Indication: Routine 2018 95,747
TX_PVLS_den Denominator: Indication: Targeted 2018 1,500
TX_PVLS_den Denominator: Indication: Targeted 2018 16,507
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 24
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 18,295
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 277
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 3,102
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 24
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 18,295
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 277
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 3,099
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 76
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,861
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 76
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,861
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 974
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 21,498
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 460
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 10,116
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 1,579
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 35,301
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 2,108
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 44,126
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 101
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,317
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 101
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,317
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,302
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 26,875
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 613
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 12,644
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 1,133
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 46,650
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 127
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 5,183
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 4
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 74
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 4
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 74
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 77
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 3,239
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 44
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 1,802
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 43
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 713
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 43
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 713
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 677
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 376
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 29,116
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 16,162
Cross Cutting Budget Categories and Known Amounts Total: $1,068,137
Key Populations: MSM and TG $20,000
Training of health workers and community outreach workers
Key Populations: Sex Workers $80,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Gender: Gender Based Violence (GBV) $333,099
GBV Prevention
Gender: Gender Equality $150,000
Changing harmful gender norms and promoting positive gender norms
Food and Nutrition: Policy, Tools, and Service Delivery $50,000
Renovation $190,000
Condoms: Policy, Tools, and Services $22,298
Motor Vehicles: Purchased $190,000
Human Resources for Health $32,740